MeSH Browser

MeSH Heading: Myoclonic Epilepsies, Progressive
Tree Number(s): C10.228.140.490.375.130.650; C10.228.140.490.493.063.650
Unique ID: D020191
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D020191
Scope Note: A heterogeneous group of primarily familial EPILEPSY disorders characterized by myoclonic seizures, tonic-clonic seizures, ataxia, progressive intellectual deterioration, and neuronal degeneration. These include LAFORA DISEASE; MERRF SYNDROME; NEURONAL CEROID-LIPOFUSCINOSIS; sialidosis (see MUCOLIPIDOSES), and UNVERRICHT-LUNDBORG SYNDROME.
Entry Term(s): Action Myoclonus-Renal Failure Syndrome; Ataxia, Chorea, Seizures, And Dementia; Atypical Inclusion-Body Disease; Biotin-Responsive Encephalopathy; Dentatorubral-Pallidoluysian Atrophy; Familial Progressive Myoclonic Epilepsy; Haw River Syndrome; May-White Syndrome; Myoclonic Epilepsy, Progressive; Myoclonus-Nephropathy Syndrome; Naito Oyanagi Disease; Naito-Oyanagi Disease; Progressive Myoclonic Epilepsy; Progressive Myoclonus Epilepsies
Previous Indexing: Epilepsies, Myoclonic (1977-1999); Epilepsy (1965-1999); Myoclonus (1968-1999)
Public MeSH Note: 2000; see Epilepsy, Myoclonic 1977-1999
History Note: 2000; use Epilepsy, Myoclonic 1977-1999
Date Established: 2000/01/01
Date of Entry: 1999/11/04
Revision Date: 2017/02/24

Allowable Qualifiers: blood (BL)

cerebrospinal fluid (CF)

chemically induced (CI)

classification (CL)

complications (CO)

congenital (CN)

diagnosis (DI)

diagnostic imaging (DG)

diet therapy (DH)

drug therapy (DT)

economics (EC)

embryology (EM)

enzymology (EN)

epidemiology (EP)

ethnology (EH)

etiology (ET)

genetics (GE)

history (HI)

immunology (IM)

metabolism (ME)

microbiology (MI)

mortality (MO)

nursing (NU)

parasitology (PS)

pathology (PA)

physiopathology (PP)

prevention & control (PC)

psychology (PX)

radiotherapy (RT)

rehabilitation (RH)

surgery (SU)

therapy (TH)

urine (UR)

veterinary (VE)

virology (VI)

Myoclonic Epilepsies, Progressive MeSH Descriptor Data 2025